411 related articles for article (PubMed ID: 30922804)
1. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K
Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804
[TBL] [Abstract][Full Text] [Related]
2. Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis.
Porpiglia M; Borella F; Chieppa P; Brino C; Ala A; Marra V; Castellano I; Benedetto C
Tumori; 2023 Jun; 109(3):301-306. PubMed ID: 35751383
[TBL] [Abstract][Full Text] [Related]
3. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
4. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S
Breast Cancer Res Treat; 2022 Jun; 193(3):589-595. PubMed ID: 35451733
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A
Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node.
Patel R; MacKerricher W; Tsai J; Choy N; Lipson J; Ikeda D; Pal S; De Martini W; Allison KH; Wapnir IL
Ann Surg Oncol; 2019 Aug; 26(8):2452-2458. PubMed ID: 31087176
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.
Wu S; Wang Y; Zhang N; Li J; Xu X; Shen J; Liu G
Ann Surg Oncol; 2018 Oct; 25(11):3150-3157. PubMed ID: 30083833
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.
Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Chae YS; Lee SJ
Ann Surg Oncol; 2018 Feb; 25(2):494-500. PubMed ID: 29134374
[TBL] [Abstract][Full Text] [Related]
10. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients.
Choy N; Lipson J; Porter C; Ozawa M; Kieryn A; Pal S; Kao J; Trinh L; Wheeler A; Ikeda D; Jensen K; Allison K; Wapnir I
Ann Surg Oncol; 2015 Feb; 22(2):377-82. PubMed ID: 25164040
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Park S; Koo JS; Kim GM; Sohn J; Kim SI; Cho YU; Park BW; Park VY; Yoon JH; Moon HJ; Kim MJ; Kim EK
Cancer Res Treat; 2018 Jul; 50(3):801-812. PubMed ID: 28814071
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
Nijveldt JJ; Rajan KK; Boersma K; Noorda EM; van der Starre-Gaal J; Kate MV'V; Roeloffzen EMA; Vendel BN; Beek MA; Francken AB
Ann Surg Oncol; 2024 Jul; 31(7):4477-4486. PubMed ID: 38523225
[TBL] [Abstract][Full Text] [Related]
13. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
[TBL] [Abstract][Full Text] [Related]
14. A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients.
Goyal A; Puri S; Marshall A; Valassiadou K; Hoosein MM; Carmichael AR; Erdelyi G; Sharma N; Dunn J; York J
Breast Cancer Res Treat; 2021 Jan; 185(2):433-440. PubMed ID: 33025481
[TBL] [Abstract][Full Text] [Related]
15. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study.
Baker JL; Haji F; Kusske AM; Fischer CP; Hoyt AC; Thompson CK; Lee MK; Attai D; DiNome ML
Breast Cancer Res Treat; 2022 Jan; 191(1):107-114. PubMed ID: 34652548
[TBL] [Abstract][Full Text] [Related]
16. Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?
Horváth Z; Paszt A; Simonka Z; Látos M; Kaizer L; Hamar S; Vörös A; Ormándi K; Fejes Z; Lázár G
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):504-510. PubMed ID: 31708307
[TBL] [Abstract][Full Text] [Related]
17. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM
Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
Murphy BL; L Hoskin T; Heins CDN; Habermann EB; Boughey JC
Ann Surg Oncol; 2017 Sep; 24(9):2518-2525. PubMed ID: 28484921
[TBL] [Abstract][Full Text] [Related]
20. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM
J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
